Plain-English translation of NCT07614659 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a convenient home-based screening program can catch heart disease risk factors—like high blood pressure, high cholesterol, diabetes, and irregular heartbeat—earlier than standard care. If you're in the screening group, you'll measure your blood pressure at home, provide a small finger-prick blood sample by mail, and answer questions about your health. The study wants to see if this approach helps more people get treated before serious problems develop.
Many people have heart disease risk factors but don't know it because they never get screened. This trial exists to find out whether making screening easier—by doing it at home instead of at a clinic—can help more people discover and treat these conditions early, when treatment is most effective.
You likely qualify if…
You likely don't qualify if…
If you're randomly assigned to the screening group, you'll receive a package at home containing a blood pressure monitor, a kit to collect a tiny blood sample from your finger (which you mail back), and a digital questionnaire about your health and lifestyle. You'll take your blood pressure readings over 7 days and submit your sample and answers. Your results will be shared with you online, and if anything concerning is found, your doctor will contact you about starting treatment or follow-up care. The control group continues with regular doctor visits as usual, and researchers will track both groups' health outcomes over time using medical records.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
Sweden
Sponsor
Johan Sundström
Collaborators
Region Uppsala
Enrollment target
~45,000 participants
Started
February 2025
Primary completion
December 2027
Age range
50 Years – 75 Years
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Johan Sundström, MD, PhD
Uppsala University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.